Shares of Relx PLC (NYSE:RELX) have been assigned an average rating of “Buy” from the twelve brokerages that are presently covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company.
Several equities analysts have commented on RELX shares. UBS Group reissued a “neutral” rating on shares of Relx in a research report on Friday. Zacks Investment Research raised Relx from a “sell” rating to a “hold” rating in a report on Tuesday, September 22nd. Societe Generale restated a “buy” rating on shares of Relx in a report on Friday. Berenberg Bank reiterated a “hold” rating on shares of Relx in a report on Thursday, July 30th. Finally, Barclays restated an “overweight” rating on shares of Relx in a research note on Friday.
Shares of Relx stock traded down $0.44 during midday trading on Friday, reaching $20.96. 33,402 shares of the company’s stock traded hands, compared to its average volume of 821,489. The company has a debt-to-equity ratio of 3.15, a quick ratio of 0.42 and a current ratio of 0.47. Relx has a 52 week low of $16.81 and a 52 week high of $27.25. The company’s 50 day simple moving average is $22.43 and its 200 day simple moving average is $22.69. The company has a market cap of $41.33 billion, a price-to-earnings ratio of 17.98, a price-to-earnings-growth ratio of 3.41 and a beta of 0.56.
Relx Company Profile
RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.
Featured Article: Street Name
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.